Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial

Overexpression of epidermal growth factor receptor can be found in more than 80% of patients with locoregionally advanced nasopharyngeal carcinoma and is associated with shorter survival. In this work, we evaluated the feasibility of adding nimotuzumab to chemoradiation in locoregionally advanced na...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Huang, Jian-feng, Zhang, Fu-zheng, Zou, Qin-zhou, Zhou, Le-yuan, Yang, Bo, Chu, Jian-jun, Yu, Jia-hua, Zhang, Hao-wen, Yuan, Xiao-peng, Tai, Guo-mei, Liu, Fen-ju, Ma, C-M Charlie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356815/
https://ncbi.nlm.nih.gov/pubmed/27974693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13899
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi